Skip to main content
. Author manuscript; available in PMC: 2019 Nov 8.
Published in final edited form as: J Am Coll Cardiol. 2018 Nov 11;73(6):629–638. doi: 10.1016/j.jacc.2018.11.001

CENTRAL ILLUSTRATION. Survival Curves According to the Revascularization Strategy in the FREEDOM Follow-On Study.

CENTRAL ILLUSTRATION

KapLan-Meier estimates and survival curves including all patients enrolled in the FREEDOM (Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease) trial (whole cohort of patients). Coronary artery bypass grafting results in a Long-term survival benefit in patients with diabetes and multivessel coronary disease when compared with revascularization with percutaneous coronary intervention with drug-eluting stents.